ACHIEVING
BOLD AMBITIONS

For more than 35 years, we've been tackling some of the world’s greatest public health challenges. We've revolutionized HIV treatment and prevention, delivered a cure for hepatitis C and made advancements in therapies for viral diseases and certain cancers.

Now, we’ve announced our plans to enable access to our investigational medication for HIV prevention, if approved, across 120 high-incidence, resource-limited countries. This reflects our ongoing commitment to providing rapid, broad and sustainable access to our medicines.